Myelopathy after the intrathecal administration of hypertonic saline.
The neuropathological effects of intrathecally administered hypertonic saline have not been described previously. We report a patient who, within a day of receiving 20 ml of hypertonic (7.5%) saline intrathecally, developed flaccid paraplegia and complete sensory loss below the umbilicus. Subsequently, there was some transitory return of motor and coarse sensory function. The patient died 16 months after the injection. At autopsy, there was peripherally accentuated loss of myelinated fibers within the spinal cord from T12 downward, as well as dense collagenous thickening of the dorsal leptomeninges from T9 to T11. The findings in this case, coupled with observations made by others, serve to emphasize the need for extreme caution whenever planning any form of intrathecal therapy.
Kim
R C
RC
Laboratory Service, Veterans Administration Medical Center, Long Beach, California.
Porter
R W
RW
Choi
B H
BH
Kim
S W
SW
D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D010264:Paraplegia / Q000139:chemically induced* / Q000473:pathology; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage / Q000009:adverse effects*; D012965:Sodium Chloride / Q000009:adverse effects*; D013116:Spinal Cord / Q000473:pathology*
D012462:Saline Solution, Hypertonic; D012965:Sodium Chloride